PTC Therapeutics has filed a notice of an exempt offering of securities to raise $35,897,425.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, PTC Therapeutics is raising $35,897,425.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Stuart Peltz played a key role…
